Rena Therapeutics
About:
Rena Therapeutics is a creation of new nucleic acid drugs realized by third-platform technology
Website: https://www.renatherapeutics.com/
Top Investors: Innovation Network Corporation of Japan, DBJ Capital, KSP, Nippon Shokubai
Description:
In the pharmaceutical market, attention has been focused on nucleic acid drugs to meet unmet medical needs such as cancer and intractable diseases.This is because nucleic acid drugs have the following advantages.It is possible to target intracellular drug molecules that could not be targeted by conventional drugsDrug discovery research is possible for any gene as long as there is technology to deliver nucleic acids to the expression siteMore specific than low molecular weight compounds and less susceptible to side effects Unlike antibody drugs, nucleic acid drugs can be manufactured by chemical synthesis at a relatively low cost.
1.2B JPY
$1M to $10M
Tokyo, Tokyo, Japan
2015-01-15
Junichi Yano
11-50
2017-06-30
Private
© 2025 bioDAO.ai